Zacks Research Brokers Boost Earnings Estimates for Nutrien

Nutrien Ltd. (NYSE:NTR) – Zacks Research raised their Q2 2027 earnings per share (EPS) estimates for Nutrien in a research report issued to clients and investors on Wednesday, April 15th. Zacks Research analyst Team now expects that the company will post earnings per share of $1.87 for the quarter, up from their previous estimate of $1.84. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Nutrien’s current full-year earnings is $3.72 per share. Zacks Research also issued estimates for Nutrien’s Q3 2027 earnings at $0.93 EPS, Q1 2028 earnings at $0.64 EPS and FY2028 earnings at $4.59 EPS.

A number of other research firms have also commented on NTR. BMO Capital Markets lifted their price objective on Nutrien from $85.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 18th. Morgan Stanley lifted their price objective on Nutrien from $77.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 8th. UBS Group lowered Nutrien from a “neutral” rating to a “sell” rating and lifted their price objective for the stock from $63.00 to $67.00 in a research note on Thursday, March 26th. Royal Bank Of Canada lifted their price objective on Nutrien from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 7th. Finally, Raymond James Financial lifted their target price on Nutrien from $68.00 to $74.00 and gave the stock a “market perform” rating in a research report on Friday, February 20th. Ten research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $79.65.

Nutrien Price Performance

Shares of NYSE:NTR opened at $74.49 on Thursday. Nutrien has a fifty-two week low of $51.98 and a fifty-two week high of $85.36. The business has a 50-day moving average of $74.49 and a two-hundred day moving average of $65.61. The stock has a market capitalization of $35.82 billion, a P/E ratio of 15.99 and a beta of 0.69. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.34 and a quick ratio of 0.70.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same period in the prior year, the firm earned $0.31 EPS. Nutrien’s quarterly revenue was up 5.1% on a year-over-year basis.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 3.0%. This is a boost from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend was Tuesday, March 31st. Nutrien’s dividend payout ratio (DPR) is 47.21%.

Institutional Investors Weigh In On Nutrien

Institutional investors have recently added to or reduced their stakes in the stock. Montag A & Associates Inc. boosted its holdings in Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares in the last quarter. Sfam LLC acquired a new stake in Nutrien during the fourth quarter valued at approximately $37,000. Root Financial Partners LLC acquired a new stake in Nutrien during the third quarter valued at approximately $37,000. Eastern Bank boosted its holdings in Nutrien by 133.0% during the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after purchasing an additional 399 shares in the last quarter. Finally, Harbour Investments Inc. raised its stake in shares of Nutrien by 97.2% in the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after acquiring an additional 347 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.